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During  pregnancy,  incessant  tachyarrhythmias  may  result  in  hemodynamic  compromise  in both the
expectant  mother  and the  fetus.  The  use  of  antiarrhythmic  drugs  is  typically  not safe  during  preg-
nancy,  and  some  tachycardias  are  refractory  to pharmacologic  treatment  due  to a  signiﬁcant  autonomic
imbalance.  Catheter  ablation  is  thought  to  be more  effective  than  medical  therapy,  but  carries  the
risk  of  radiation  exposure  to the  fetus.  We  report  two cases  of  hemodynamically  unstable  incessant
atrial  tachycardia  (AT) in  pregnant  women.  Both  ATs resolved  after  three-dimensional  electroanatomical
mapping-guided  radiofrequency  catheter  ablation  with  minimal  ﬂuoroscopic  exposure.  But one of  theatheter ablation
lectroanatomical mapping
ulmonary embolism
patients  experienced  a pulmonary  embolism  immediately  after  the  procedure  and  miscarried.
<Learning objective:  Although  catheter  ablation  using  electroanatomical  mapping  is an  effective  treat-
ment  for  incessant  atrial  tachycardia  in  pregnant  women  and minimizes  radiation  exposure  to  the  fetus,
patients  should  be  closely  monitored  during  the  peri-procedural  period  due  to  the  risk  of  pregnancy-
associated  complications  such  as pulmonary  embolism.>
©  2014  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.ntroduction
Incessant tachyarrhythmia during pregnancy is a difﬁcult clini-
al problem to manage, since antiarrhythmic drugs have potential
dverse effects on the fetus and some tachycardias are refractory
o pharmacologic therapy [1]. Historically, physicians have been
esitant to perform radiofrequency catheter ablation (RFCA) due
o concerns about fetal radiation exposure. We  report two  cases
f incessant atrial tachycardia (AT) successfully resolved by RFCA
sing a three-dimensional (3D) electroanatomic mapping system
ith minimal radiation exposure.
ase reports
The ﬁrst case was a 30-year-old woman at 17 weeks gestation
ho had been suffering from chest ﬂuttering and New York Heart
ssociation class III shortness of breath for two weeks. On physi-
al examination, she had a signiﬁcant jugular venous engorgement
nd S3 gallop. An electrocardiogram (ECG) showed narrow QRS
∗ Corresponding author at: 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic
f  Korea. Tel.: +82 2 2228 8459; fax: +82 2 393 2041.
E-mail address: hnpak@yuhs.ac (H.-N. Pak).
ttp://dx.doi.org/10.1016/j.jccase.2014.02.001
878-5409/© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights retachycardia with a cycle length of 280 ms  and QRS amplitude alter-
nans (Fig. 1A). Echocardiography showed a reduced left ventricular
ejection fraction (LVEF) of 38%, suggesting tachycardiomyopathy.
After fetal evaluation and discussion with obstetricians, we con-
cluded that RFCA might be the best option for this patient. The
electrophysiological intervention was  performed without seda-
tion. During the procedure, the patient’s abdomen and pelvis were
shielded with a 0.25-mm lead apron to protect the fetus from radi-
ation. After right groin puncture, we  used a 12Fr Trio sheath (St.
Jude Medical Inc., Minnetonka, MN,  USA) and an 8Fr Schwarz left 1
long sheath (St. Jude Medical Inc.), and then positioned the mapping
catheter minimizing radiation exposure (Fig. 1C). And we  generated
3D electroanatomical maps (NavX, St. Jude Medical Inc.) using a 20-
pole Lasso catheter (7Fr, Johnson & Johnson, Diamond Bar, CA, USA)
to shorten the radiation time. The resultant high density activation
map (over 350 points on bipolar electrogram) showed the focus of
AT to be the sinus venosus (Fig. 1E), which matched the earliest
activation site identiﬁed on bipolar catheter mapping (Fig. 1D). AT
was neither entrained nor pace-terminated at the potential target
site, suggesting a non-reentrant mechanism, and RFCA successfully
terminated the tachycardia within 15 s of energy delivery. The total
ﬂuoroscopy time was 6 min, and the total radiation dose adminis-
tered was  35.1 mGy. Normal sinus rhythm was subsequently main-
tained without further intervention (Fig. 1B). After the procedure,
served.
214 P.-S. Yang et al. / Journal of Cardiology Cases 9 (2014) 213–216
Fig. 1. (A) 12-Lead electrocardiogram (ECG) from the ﬁrst case showing atrial tachycardia. (B) ECG after successful atrial tachycardia ablation. (C) Catheter positions in the left
anterior  oblique (LAO) 35◦ view. (D) Intracardiac recording during an electrophysiology study showing that the earliest atrial activation was  recorded at the sinus venosus.
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SE)  NavX 3D activation map  (left) and voltage map  (right) from the right posterior o
oltage area on the sinus venosus. Ablation sites are depicted by white circles.
er LVEF improved from 38% to 68% on echocardiography, and the
atient delivered a healthy full-term baby.
The second case was that of a 32-year-old woman  at 21 weeks
estation who presented with incessant tachycardia and shortness
f breath that had been worsening over the previous 2 months. Her
T was incessant despite receiving amiodarone and -blockers, at
hich time the patient was referred to our facility. On physical
xamination, she had pulmonary and peripheral venous congestion
nd S3 gallop. An ECG showed AT with a heart rate of 160 bpm, neg-
tive P-wave polarity in V1 and aVR, and positive P-wave polarity in
,  II, III, aVF, and aVL (Fig. 2A). Echocardiography revealed cardiomy-
pathy with a LVEF 18%. It was initially difﬁcult to differentiate
etween tachycardiomyopathy, peri-partum cardiomyopathy, and
cute exacerbation of dilated cardiomyopathy, although incessant
T was thought to be a major contributor to her heart failure symp-
oms as well as fetal distress. Therefore, after discussions with
bstetricians and her family, we chose to perform RFCA. We used
he same right groin approach for mapping and ablation in this
econd patient too, but, unfortunately, we did not use heparin.
elvic protection with a 0.25-mm lead apron was also applied. An
ntracardiac electrogram showed the earliest AT activation site to
e along the free wall of right atrium (RA) (Fig. 2C). We  successfully
apped and ablated AT originating from this site after high den-
ity (over 400 points on RA) 3D electroanatomical mapping (NavX,
t. Jude Medical Inc.; Fig. 2D and E). Total ﬂuoroscopy time wase view. The earliest activation site is localized at the border of the scar and the low
60  s and the total radiation dose administered was  13.5 mGy. At
the end of procedure, the patient’s condition began to deteriorate
as she showed signs of severe hypoxemia, tachypnea, and hypoten-
sion. Her hypoxemia was  not corrected by high-ﬂow oxygen, and
she was subsequently intubated and underwent artiﬁcial venti-
lation. Her alveolar–arterial oxygen gradient (A–a DO2) was high
(159 mmHg) and her plasma D-dimer level was extremely elevated
(6478 ng/mL). Pregnancy is a risk factor for developing a pulmonary
embolism (PE), and she had additionally undergone a transve-
nous catheter procedure. Intravenous unfractionated heparin was
immediately infused for a clinical diagnosis of acute PE, although
pulmonary computed tomography angiography was not conducted
in order to avoid further radiation exposure. After several hours of
heparinization and mechanical ventilation, the patient’s vital signs
stabilized but the baby did not survive. The patient recovered with-
out complications after abortion and remained in sinus rhythm
(Fig. 2B). Additionally, her LVEF improved from 19% to 40% during
the 9-month follow-up period.
DiscussionAT is a relatively common arrhythmia during pregnancy, and
typically self-limited. In some cases, however, the patient may
develop incessant tachycardia which can induce tachycardiomy-
opathy [2,3]. Tachycardiomyopathy increases the risk of fetal
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Fig. 2. (A) 12-Lead electrocardiogram (ECG) from the second case showing atrial tachycardia originating from the high crista terminalis. (B) ECG after successful atrial
t n site 
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cachycardia (AT) ablation. (C) Intracardiac electrogram showing the earliest activatio
ap  showing a centrifugal pattern of activation originating from the free wall of the
blation sites are depicted by white circles.
istress and death [4,5]. Generally, antiarrhythmic drugs are
ot recommended during pregnancy due to the risk of adverse
ffects such as teratogenicity [1]. The American College of Cardi-
logy/American Heart Association guidelines recommend RFCA in
regnant patients with poorly tolerated supraventricular arrhyth-
ias that are refractory to pharmacologic therapy [6]. Low-dose
adiation of <50 mGy  has been shown to have no signiﬁcant adverse
ffects on the fetus [7]. Moreover, 3D electroanatomical mapping
8] or intracardiac echocardiography [9] can further minimize radi-
tion exposure.
It  is important to consider the differences in physiology during
regnancy when deciding on a treatment strategy for AT, regard-
ess of the known reduction in radiation and convenience of RFCA.
nfortunately, one of our patients experienced miscarriage due to
 procedure-related PE. There were several factors contributing to
his unexpected event. First, pregnant status itself increases the
isk of thromboembolism [10]. All three factors in Virchows’s triad
blood stasis, hypercoagulability, and endothelial injury) are rel-
vant to a pregnant state. During pregnancy, mechanical venous
ompression by uterus and decreased mobility lead to venous stasis
f lower extremity. Pregnancy is associated with a hypercoagula-
le state by physiological increase in pro-coagulant factors, such as
actors VII, VIII, X, and von Willebrand factor, and decrease in anti-
oagulant factors, such as protein C and S. Endothelial injury alsoof AT to be on the free wall of the right atrium (RA) (ABLds). (D) 3D electroanatomical
E) Voltage map  of the RA suggests a low voltage area around the tachycardia focus.
frequently  occurs during pregnancy. Second, the associated heart
failure contributed to the venous congestion and low extremity
venous thrombosis. Third, she underwent RFCA which is known
to increase the thrombogenicity, and catheter movement through
the femoral vein might embolize the venous thrombosis. A series
of above-mentioned risk factors must have led to the pulmonary
thromboembolic event. Therefore, very careful venous catheter-
ization and prophylactic heparinization are strongly recommended
to prevent thromboembolic events in pregnant women undergo-
ing RFCA. Heparin is a drug classiﬁed as Pregnancy Category C.
But, heparin is generally considered safe to use during pregnancy,
because it does not cross the placenta due to its large molecu-
lar weight [10]. In addition, there is no evidence to increase the
risk of maternal complications, such as hemorrhage, abortion, or
heparin-induced thrombocytopenia. If a pregnant woman has risk
factors for thrombosis, such as past history of thromboembolism,
inherited or acquired thrombophilia, and is undergoing an intravas-
cular procedure, heparin can be used to prevent thromboembolic
events.
The diagnosis of tachycardiomyopathy from peri-partum car-
diomyopathy versus exacerbation of dilated cardiomyopathy is
sometimes difﬁcult to make, especially prior to assessing outcomes
after rhythm control. The LVEF of the ﬁrst patient was normalized,
while that of the second patient was partially recovered after
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uccessful rhythm control. Therefore, extreme caution should
e taken when making diagnostic or therapeutic decisions for
regnant patients, and a thorough explanation of the risks and
eneﬁts should be given to the patient and her family prior to
aking decisions regarding management.
In conclusion, RFCA with 3D electroanatomic mapping tech-
ology is a viable therapeutic option for the treatment of
achyarrhythmias in pregnancy. However, the risk of potential
regnancy-speciﬁc complications such as PE requires close mon-
toring during the peri-procedural period.
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